Orofluco (Fluconazole)

Fluconazole, the active ingredient in Orofluco, is a azole antifungal presented as an oral tablet for oral use. It treats a range of fungal infections including candidiasis, cryptococcal meningitis and dermatophyte infections in adults and children as prescribed by a healthcare professional.

GNH USA supplies Orofluco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Fluconazole is an azole antifungal that interferes with fungal cell membrane synthesis, making it effective for several systemic and mucosal fungal diseases.

- Candidiasis: resolves oropharyngeal, esophageal, vaginal and systemic Candida infections. - Cryptococcal meningitis: provides targeted therapy for cryptococcal infection of the central nervous system. - Dermatophyte infections: treats skin and nail infections caused by dermatophyte fungi.

Fluconazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset that usually resolves without intervention. - Headache: occasional tension‑type headache. - Diarrhea: loose stools that are generally self‑limiting. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Hepatotoxicity: signs of liver injury such as jaundice or elevated liver enzymes. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac arrhythmias: QT interval prolongation leading to irregular heartbeats.

Before initiating fluconazole therapy, consider the following safety measures.

- Liver function monitoring: assess baseline hepatic enzymes and repeat if clinically indicated. - Drug‑induced QT prolongation: avoid use in patients with known cardiac conduction disorders. - Pregnancy counseling: discuss potential risks and benefits with a qualified obstetric provider. - Breastfeeding guidance: evaluate infant exposure and advise accordingly. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Fluconazole can alter the plasma concentrations of several co‑administered medicines, requiring careful management.

Major Interactions (Avoid): - Cisapride: increased risk of serious cardiac arrhythmias. - Certain statins (e.g., simvastatin): heightened risk of myopathy and rhabdomyolysis.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect; monitor INR more frequently. - Oral hypoglycemics (e.g., sulfonylureas): potential for hypoglycemia; adjust dose as needed.